Methicillin-resistant Staphylococcus aureus in the western region of Saudi Arabia: prevalence and antibiotic susceptibility pattern

Ann Saudi Med. 2012 Sep-Oct;32(5):513-6. doi: 10.5144/0256-4947.2012.513.

Abstract

Background and objectives: Methicillin-resistant Staphylococcus aureus (MRSA) emerged in 1960 and was a problem confined largely to the healthcare setting, or hospital-associated MRSA (HA-MRSA). In the 1990s, community-associated MRSA (CA-MRSA) infections appeared. In Saudi Arabia, the prevalence of MRSA has increased in the past ten years and severe community-acquired infection has been reported. Our objective was to investigate the prevalence of MRSA and their antibiotic susceptibilities in the western region of Saudi Arabia.

Design and setting: A retrospective review of the medical records of 186 S aureus infected patients diagnosed from November 2009 through October 2010.

Methods: S aureus was Identified based on Gram stain, catalase and coagulase tests. Susceptibility testing was performed using antibiotic discs and the VITEK 2 system.

Results: MRSA was isolated in 39.5% of the specimens. The isolates were commonly associated with wound, skin, and soft tissue infections (87.3%). The prevalence of MRSA was highest among patients who were 56 years old or older (52.2%). CA-MRSA infections represented 31.5% of community S aureus infections, while HA-MRSA accounted 52.6% of hospital S aureus (P=.0029). All MRSA isolates in our study were susceptible to vancomycin, linozolid and teicoplanin. However, multi-resistance was observed in 29.1% of the isolates and was significantly higher among HA-MRSA (P=.03).

Conclusions: The prevalence of MRSA was 39.5%, and infection was commonly associated with wound, skin, and soft tissue infections. MRSA was more prevalent in hospitals and among older patients. All MRSA susceptible to vancomycin, linozolid and teicoplanin.

MeSH terms

  • Adolescent
  • Adult
  • Female
  • Humans
  • Male
  • Methicillin-Resistant Staphylococcus aureus*
  • Microbial Sensitivity Tests
  • Middle Aged
  • Prevalence
  • Retrospective Studies
  • Staphylococcal Infections / epidemiology*
  • Staphylococcal Infections / microbiology*
  • Staphylococcus aureus / drug effects*
  • Young Adult